The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment
-
Published:2022-12
Issue:8
Volume:62
Page:684-688
-
ISSN:1877-0320
-
Container-title:Revue Française d'Allergologie
-
language:en
-
Short-container-title:Revue Française d'Allergologie
Author:
Atayik E.,Aytekin G.
Subject
Immunology and Allergy
Reference19 articles.
1. Virology, Epidemiology, Pathogenesis, and Control of COVID-19;Jin;Viruses,2020
2. Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19;Passante;Dermatol Ther,2021
3. Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma;Bousquet;Chest,2004
4. Omalizumab and COVID-19 treatment: Could it help?;Abdelmaksoud;Dermatol Ther,2020
5. Comment on “Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab”;Abdelmaksoud;Int J Dermatol,2020
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献